C39 BIOMARKERS AND PROGNOSTIC FACTORS IN ILD: A Comparative Analysis Of Rates Of Diagnosis, Treatment Initiation, And Treatment Persistence In Idiopathic Pulmonary Fibrosis (ipf) Versus Non-Small-Cell Lung Cancer (nsclc)

Methods: Using epidemiological data gathered through a combination of literature searches (prevalence rates) and proprietary primary research (IPF diagnosis, treatment initiation and persistence rates), the proportion of patients moving between each stage of the patient journey (presentation of symp...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of respiratory and critical care medicine Vol. 195
Main Authors Denton, J, Phillips, C, Del Carlo, A, Mavaddat, A, Carter, E, Dejonckheere, F, Munk, V C, Molnar, E
Format Journal Article
LanguageEnglish
Published New York American Thoracic Society 01.01.2017
Subjects
Disease
Lung cancer
Medical diagnosis
Medical prognosis
Patients
Pulmonary fibrosis
United Kingdom > UK
United States > US
Italy
France
Germany
Spain
Online AccessGet full text

Cover

More Information
Summary:Methods: Using epidemiological data gathered through a combination of literature searches (prevalence rates) and proprietary primary research (IPF diagnosis, treatment initiation and persistence rates), the proportion of patients moving between each stage of the patient journey (presentation of symptoms, diagnosis, treatment initiation, and treatment persistence) for both IPF and NSCLC was simulated. Factors with the highest impact on treatment persistence in IPF included suboptimal management of adverse events and lack of patient education on the benefits of treatment.
ISSN:1073-449X
1535-4970